60% of the doses of AstraZeneca vaccine that were distributed to health facilities for vaccinating health workers have been already administered, epidemiologist Alexei Ceban, of the National Public Health Agency’s Vaccine Preventable Diseases Epidemiological Surveillance Division, told a news conference. According to him, the vaccine is supplied free to state and private medical institutions, IPN reports.

Laura Ţurcan, epidemiologist of the National Public Health Agency, related that on the third vaccination week, there were reported a total of 712 adverse events following vaccination (3.3% frequency) after immunizing over 21,000 persons. 91% of the adverse events following vaccination are mild and include weakness, high fever, joint pain, other allergic reactions with eruptions on arms and face. They all lasted for at most two days. As to the man from Hâncești who died the next day after he was vaccinated, Laura Țurcan said the man’s death has nothing to do with the vaccine.

According to Ninel Revenco, coordinator of the national vaccination communication group, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency said the benefit of vaccination with AstraZeneca is vastly superior to the adverse events following vaccination. The Committee informed that over 20 million people were vaccinated in the UK and the EU and the adverse events are seldom. It thus reiterated that the causal relationship between post-vaccination effects and vaccination wasn’t determined and immunization with this vaccine was resumed in Italy, France, Spain, Germany, Bulgaria, Latvia, Lithuania, Cyprus, and the Netherlands. The vaccine is safe and protects 100% from serious forms of infection and deaths due to COVID-19.

Ninel Revenco noted that the vaccination process globally takes place at a positive pace and over 10 million people are vaccinated daily.